Achiron A, Mandel M, Dreyer-Alster S, Harari G, et al. Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study. J Neuroimmunol 2021;361:577746.
PMID: 34655991